Pharma giant increases profits by 31% as brands shine

The Irish arm of pharma giant Novartis last year increased its profits by 31% on the back on strong performance by a number of brands.

In accounts filed by Novartis Ireland Ltd to the Companies Office, the firm increased its pre-tax profits from €1.4m to €1.86m.

This followed revenues at the firm increasing from €61.9m to €66.4m in the 12 months to the end of Dec 2012.